Under a final rule published in the Federal Register, the pain reliever tramadol is classified as a Schedule IV controlled substance (CS) starting August 18, 2014. Drug Enforcement Administration (DEA) will require manufacturers to print the “C-IV” designation on all labels that contain tramadol, including its salts, isomers, and salts of isomers.
More Latest News
April 15, 2021
The CDC Clinician Outreach and Communication Activity (COCA) will be hosting a call at 2:00 PM ET regarding CVST associated with the Johnson & Johnson Janssen COVID-19 vaccine Continue reading